European Pharmaceutical Review

DECEMBER 14, 2023

Our research showed that in Europe between 1999 and 2016, 35 products were withdrawn. Initiatives in the UK such as the Clinical Practice Research Datalink (CPRD), The Health Improvement Network (THIN) and OpenSAFELY support UK, European, and international studies. Meta-analyses contributed least frequently (31.4

Medicine 111

Medicine Safety Competition Networking 111

European Pharmaceutical Review

JULY 5, 2022

There is an urgent need for more effective chemotherapy treatments with less severe toxicity and side effects. Irinotecan – also known by the brand name Campto/Camptosar ® (Pfizer Ltd.) – has proven to be an effective chemotherapy agent against several types of gastrointestinal cancer. 5): V38-V49.

Patients 81

Patients Food and Drug Administration Side effects Safety 81

European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

Food and Drug Administration 75

Food and Drug Administration Safety Patients Leads 75

Pharmaceutical Technology

JUNE 20, 2023

Since some drugs and medical products can have severe side effects if used incorrectly, MT engines used to translate such critical information such as dosage instructions, must be checked and edited by human translators. Neural networks learn to “translate” from language A to language B.

Electronics 52

Electronics Medical Healthcare Healthcare 52